202 related articles for article (PubMed ID: 28088346)
1. Msi1 promotes tumor progression by epithelial-to-mesenchymal transition in cervical cancer.
Gong P; Wang Y; Gao Y; Gao M; Liu L; Qu P; Jin X; Gao Q
Hum Pathol; 2017 Jul; 65():53-61. PubMed ID: 28088346
[TBL] [Abstract][Full Text] [Related]
2. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
Liu X; Yang WT; Zheng PS
Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA NORAD upregulate SIP1 expression to promote cell proliferation and invasion in cervical cancer.
Huo H; Tian J; Wang R; Li Y; Qu C; Wang N
Biomed Pharmacother; 2018 Oct; 106():1454-1460. PubMed ID: 30119219
[TBL] [Abstract][Full Text] [Related]
4. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
5. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
[TBL] [Abstract][Full Text] [Related]
6. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
[TBL] [Abstract][Full Text] [Related]
8. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.
Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H
Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590
[TBL] [Abstract][Full Text] [Related]
9. Musashi1 regulates survival of hepatoma cell lines by activation of Wnt signalling pathway.
Chen K; Gao Q; Zhang W; Liu Z; Cai J; Liu Y; Xu J; Li J; Yang Y; Xu X
Liver Int; 2015 Mar; 35(3):986-98. PubMed ID: 24444033
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines.
Deng B; Zhang S; Miao Y; Zhang Y; Wen F; Guo K
Med Oncol; 2015 Apr; 32(4):102. PubMed ID: 25740178
[TBL] [Abstract][Full Text] [Related]
12. The long noncoding RNA HOXA11 antisense induces tumor progression and stemness maintenance in cervical cancer.
Kim HJ; Eoh KJ; Kim LK; Nam EJ; Yoon SO; Kim KH; Lee JK; Kim SW; Kim YT
Oncotarget; 2016 Dec; 7(50):83001-83016. PubMed ID: 27792998
[TBL] [Abstract][Full Text] [Related]
13. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
[TBL] [Abstract][Full Text] [Related]
14. Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition.
Kong J; Di C; Piao J; Sun J; Han L; Chen L; Yan G; Lin Z
Oncotarget; 2016 Apr; 7(15):19631-42. PubMed ID: 26933912
[TBL] [Abstract][Full Text] [Related]
15. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA HOTAIR knockdown inhibits autophagy and epithelial-mesenchymal transition through the Wnt signaling pathway in radioresistant human cervical cancer HeLa cells.
Guo X; Xiao H; Guo S; Li J; Wang Y; Chen J; Lou G
J Cell Physiol; 2019 Apr; 234(4):3478-3489. PubMed ID: 30367473
[TBL] [Abstract][Full Text] [Related]
17. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway.
Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y
Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor kinase substrate 8 promotes the metastasis of cervical cancer via the epithelial-mesenchymal transition.
Li Q; Bao W; Fan Q; Shi WJ; Li ZN; Xu Y; Wu D
Mol Med Rep; 2016 Oct; 14(4):3220-8. PubMed ID: 27573546
[TBL] [Abstract][Full Text] [Related]
19. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract][Full Text] [Related]
20. CRIP1 promotes cell migration, invasion and epithelial-mesenchymal transition of cervical cancer by activating the Wnt/β‑catenin signaling pathway.
Zhang LZ; Huang LY; Huang AL; Liu JX; Yang F
Life Sci; 2018 Aug; 207():420-427. PubMed ID: 29959029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]